Skip to main content

Grifols’ Zika Test Available for Blood Screening in Europe

A test for screening blood donations for presence of the Zika virus is now being sold in Europe by Grifols, a global developer of plasma-derived medicines that has 2,500 employees in North Carolina.

Liquidia’s Opioid Alternative Fares Well in Phase 1 Trial

Morrisville-based Liquidia Technologies has reported positive initial results from a phase 1 clinical trial of a drug candidate for relieving post-surgery pain as an alternative to addictive opioids.

Ag Biotech Summit 2018

Tuesday, February 20, 2018 11:00am


NCBiotech Portfolio Company G1 Therapeutics Raises $105M in IPO

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, became a publicly traded entity today with a $105 million initial public offering of seven million shares of stock priced at $15 a share.

Patheon Agrees to $5.2 Billion Acquisition by Thermo Fisher Scientific

Durham-based Patheon N.V., a global provider of pharmaceutical development and manufacturing services that has a large production facility in Greenville, will be acquired by Thermo Fisher Scientific in a deal worth about $5.2 billion.

Kansas Startups Take Awards at NCBiotech Ag Biotech Showcase

Two Kansas startup companies won the top prizes at NCBiotech's two-day 2017 Ag Biotech Entrepreneurial Showcase in Durham.

NCBiotech Ag Showcase: Money in Manure, Pet Meds Too

A dozen ag biotech startups pitched their wares this week to a receptive crowd at the North Carolina Biotechnology Center’s 2017 Ag Biotech Entrepreneurial Showcase at the Cotton Room in Durham.

Triangle University Angel Networks Making First Joint Investment

Angel investor networks from the Triangle’s major research universities will make their first joint investment in a medical products firm this week.


Subscribe to RSS - Triangle